Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2009, Article ID 425759, 9 pages
http://dx.doi.org/10.1155/2009/425759
Clinical Study

Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 (GLP-2): Compliance, Safety, and Effects on Quality of Life

1Department of Gastroenterology, Copenhagen University Hospital (Rigshospitalet), 2121 Copenhagen, Denmark
2Department of Anesthesia, Copenhagen University Hospital (Rigshospitalet), 2100 Copenhagen, Denmark
3Department of Biomedical Sciences, The Panum Institute, 2200 Copenhagen, Denmark
4Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital (Rigshospitalet), 2100 Copenhagen, Denmark

Received 24 March 2009; Accepted 29 May 2009

Academic Editor: Karel Geboes

Copyright © 2009 P. B. Jeppesen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

P. B. Jeppesen, P. Lund, I. B. Gottschalck, et al., “Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 (GLP-2): Compliance, Safety, and Effects on Quality of Life,” Gastroenterology Research and Practice, vol. 2009, Article ID 425759, 9 pages, 2009. https://doi.org/10.1155/2009/425759.